Recent decades have witnessed remarkable advancements in the management of muscular dystrophy. Researchers are actively exploring innovative strategies that hold promise for enhancing the lives of individuals stricken by this progressive condition. Drug development have emerged as particularly effective avenues for treating the underlying causes of